

[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI

[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
Danielle Brill Reiterated (ACAD) at Strong Buy with Increased Target to $43 on, May 31st, 2019
Danielle Brill of Raymond James, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Increased Target from $40 to $43 on, May 31st, 2019.
Danielle, nor any peers, have made any analyst calls on ACAD in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources